Renaissance Technologies - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 24 filers reported holding OBALON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$205,000
+47.5%
293,716
+204.7%
0.00%
Q1 2019$139,000
-16.3%
96,400
+20.5%
0.00%
Q4 2018$166,000
-24.2%
80,000
-1.5%
0.00%
Q3 2018$219,000
+27.3%
81,200
+13.9%
0.00%
Q2 2018$172,000
+244.0%
71,300
+388.4%
0.00%
Q1 2018$50,00014,6000.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 3,552,239$5,115,0004.70%
Tamarack Advisers, LP 2,044,440$2,944,0001.17%
Millrace Asset Group, Inc. 215,701$311,0000.26%
Moisand Fitzgerald Tamayo, LLC 6,824$297,0000.16%
HoyleCohen, LLC 104,850$151,0000.03%
Altium Wealth Management LLC 27,472$40,0000.01%
C WorldWide Group Holding A/S 274,399$395,0000.01%
HighTower Advisors, LLC 112,788$162,0000.00%
Spark Investment Management LLC 18,300$26,0000.00%
CITIGROUP INC 5,000$7,0000.00%
View complete list of OBALON THERAPEUTICS INC shareholders